Intellia Therapeutics Inc(NTLA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NTLA Intellia Therapeutics Inc

交易中 11-21 15:13:06 EST

14.00

+0.88

+6.71%

最高14.39	最低13.23	成交量231.17万
今开13.26	昨收13.12	日振幅8.84%
总市值14.26亿	流通市值14.08亿	总股本1.02亿
成交额3,223万	换手率2.30%	流通股本1.01亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NTLA","market":"US","secType":"STK","nameCN":"Intellia Therapeutics Inc","latestPrice":14,"timestamp":1732219979269,"preClose":13.12,"halted":0,"volume":2311697,"delay":0,"floatShares":100566929,"shares":101848572,"eps":-5.440543,"marketStatus":"交易中","marketStatusCode":2,"change":0.88,"latestTime":"11-21 15:13:06 EST","open":13.26,"high":14.39,"low":13.23,"amount":32226290.626197997,"amplitude":0.088415,"askPrice":14.01,"askSize":307,"bidPrice":13.99,"bidSize":428,"shortable":3,"etf":0,"ttmEps":-5.440543,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732222800000},"adr":0,"listingDate":1462507200000,"adjPreClose":13.12,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":13.23,"preClose":13.12,"latestTime":"09:29 EST","volume":29910,"amount":394051.9869,"timestamp":1732199399999},"postHourTrading":{"tag":"盘后","latestPrice":13.15,"preClose":13.12,"latestTime":"19:59 EST","volume":65244,"amount":856264.4646,"timestamp":1732150776962},"volumeRatio":0.676281,"impliedVol":0.8284,"impliedVolPercentile":0.8373},"requestUrl":"/m/hq/s/NTLA","defaultTab":"news","newsList":[{"id":"2485849722","title":"Intellia Therapeutics, Inc.盘中异动 早盘股价大涨5.34%报13.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485849722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485849722?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:40","pubTimestamp":1732200023,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时40分，Intellia Therapeutics, Inc.股票出现波动，股价快速上涨5.34%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121224023abd4ea83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121224023abd4ea83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LU1861559042.SGD","BK4556","NTLA","BK4535","LU1861558580.USD","BK4588","BK4585"],"gpt_icon":0},{"id":"2485514174","title":"Intellia Therapeutics, Inc.盘中异动 早盘急速下跌5.10%报13.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485514174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485514174?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:23","pubTimestamp":1732119798,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日00时23分，Intellia Therapeutics, Inc.股票出现异动，股价快速跳水5.10%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112100231998e43c67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112100231998e43c67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","LU1861558580.USD","LU1861559042.SGD","NTLA","BK4588","BK4535","LENZ","BK4585"],"gpt_icon":0},{"id":"1137497210","title":"异动解读 | NTLA盘后大涨5.79%,基因编辑疗法前景看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1137497210","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137497210?lang=zh_cn&edition=full","pubTime":"2024-11-19 13:44","pubTimestamp":1731995078,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics Inc(NTLA)股价今晚盘后大涨5.79%,引发市场广泛关注。\n\n公司最新公布的基因编辑疗法临床试验数据给投资者带来信心,对疗法前景充满期待。这是导致NTLA股价今晚大涨的主要原因。\n\n公司开发的基因编辑作用于多种疾病,有望为患者带来新的治疗选择。尽管目前仍处于早期阶段,但未来市场潜力巨大。投资者对于该公司长期发展前景抱有信心,推动股价大涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | NTLA盘后大涨5.79%,基因编辑疗法前景看好","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NTLA"],"gpt_icon":0},{"id":"2484607758","title":"美股走势-Henry Schein Inc、Palantir Technologies、Uber Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2484607758","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484607758?lang=zh_cn&edition=full","pubTime":"2024-11-19 03:12","pubTimestamp":1731957174,"startTime":"0","endTime":"0","summary":".N美国东部时间13:31，道琼斯工业平均指数.DJI下跌0.12%，报43,394.67点。标普500指数.SPX上涨0.42%，报5894.99点；纳斯达克综合指数.IXIC上涨0.62%，报18798.28点。标准普尔 500 指数.PG.INX百分比涨幅前三名是： ** 超级微型计算机公司SMCI.O，上涨 20.2. ** Henry Schein Inc HSIC.O，上涨 6.9 标普500指数.PL.INX跌幅前三名： ** Amentum Holdings Inc AMTM.N，下跌 9.0. 纽约证券交易所.PG.N百分比涨幅前三名： ** Finance of America Companies Inc FOA.N，上涨 21.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nL4T3MP1CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNVD.UK","CMAX","MARA","LUV","PPTA","NTLA","LBRT","GL","NVDU","DCOM","WBD","JBLU","DE","NVDS.UK","TSLA","MSTR","DAL","NVD3.UK","NVDY","2NVD.UK","HIMS","LLY","BIIB","TPR","BBWI","ASB","NVD","NEM","NKE","NVDL","NVD2.UK","TWST","MRNA","CVS","HOOD","HSIC","NVDX","AILE","3NVD.UK","NVDA","UAL","AEO","GAP","HPE","BTBT","MBI","GRNT","VSCO","VLY"],"gpt_icon":1},{"id":"2484670973","title":"BUZZ--美国股票走势-特斯拉公司、帕兰提尔科技公司和超微计算机公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2484670973","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484670973?lang=zh_cn&edition=full","pubTime":"2024-11-19 00:14","pubTimestamp":1731946466,"startTime":"0","endTime":"0","summary":"美国东部时间10:31，道琼斯工业平均指数  下跌0.18%，报43366.20点；标普500指数  上涨0.33%，报5889.99点；纳斯达克综合指数  上涨0.76%，报18821.61点。标准普尔 500 指数  百分比涨幅前三名是：** 超级微型计算机公司  ，上涨 8.5 ** 特斯拉  ，上涨8.5%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WBD","DE","LBRT","GAP","BBWI","NEM","ASB","DXD",".DJI","AILE","AEO","TSLA","GL","PPTA","NQmain","PLTR","SQQQ","CMAX","UBER","AMTM","DOG","NVDY","AKA","NVDS",".IXIC","BIIB","NTLA",".SPX","HPE","VLY","TPR","DJX","NVDA","VSCO","DCOM","SDOW","MNQmain","TSLL","SNVD.UK","TWST","MBI","CVS"],"gpt_icon":1},{"id":"2484676433","title":"BUZZ--美国股票走势-银矿商、Intellia、Robinhood","url":"https://stock-news.laohu8.com/highlight/detail?id=2484676433","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484676433?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:45","pubTimestamp":1731941147,"startTime":"0","endTime":"0","summary":".N ** 惠普公司HPE.N： BUZZ - 在券商将其评级提升至 \"强烈买入 \"后上涨 nL4N3MP0MD。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nL4T3MP129:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPR","IE00B3M56506.USD","NVDS","2NVD.UK","NEM","HK0000306701.USD","WBD","HIMS","TWST","BK4023","CDE","NTLA","BK4587","NVD","TSLA","NVDX","HOOD","HPE","CMAX","BK4532","CVS","LU2290526834.HKD","HL","LU2491050154.USD","NVDL","LU0278409577.USD","BK4529","SNVD.UK","VLY","DCOM","MRNA","NVDU","3NVD.UK","NVDA","LU1280957306.USD","NVDD","BIIB","ASB","LBRT","LU1366192091.USD","LU1839511570.USD","NVDS.UK","PPTA","NVD3.UK","BTBT","NVDY","NVD2.UK","GL","IE0004445239.USD"],"gpt_icon":1},{"id":"2484671685","title":"Intellia Therapeutics, Inc.盘中异动 股价大涨5.08%报14.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484671685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484671685?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:31","pubTimestamp":1731940276,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时31分，Intellia Therapeutics, Inc.股票出现异动，股价快速拉升5.08%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822311698e433a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822311698e433a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","LU1861558580.USD","LU1861559042.SGD","NTLA","BK4588","BK4535","LENZ","BK4585"],"gpt_icon":0},{"id":"2484627436","title":"BUZZ-Intellia因基因编辑疗法的早期数据前景看好而大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2484627436","media":"路透中文","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484627436?lang=zh_cn&edition=full","pubTime":"2024-11-18 21:28","pubTimestamp":1731936489,"startTime":"0","endTime":"0","summary":"11月18日 -  ** Intellia Therapeutics公司NTLA.O股价盘前大涨12.7%至15.75美元 ** 上周六，Intellia Therapeutics公司报告了 ，该公司针对一种名为转甲状腺素淀粉样变性的罕见疾病的基因编辑疗法取得了令人鼓舞的早期结果。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nL4T3MP0XJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","NTLA","BK4535","BK4139","BK4588","BK4585","LU1861559042.SGD","BK4556"],"gpt_icon":0},{"id":"2483305430","title":"Intellia Therapeutics, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483305430","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483305430?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:32","pubTimestamp":1731684749,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时32分，Intellia Therapeutics, Inc.股票出现异动，股价急速下跌5.03%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.18%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115233229abc506f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115233229abc506f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861559042.SGD","BK4585","BK4139","NTLA","BK4556","BK4588","LU1861558580.USD","LENZ","BK4535"],"gpt_icon":0},{"id":"2483039246","title":"Intellia Therapeutics, Inc.盘中异动 快速下挫5.11%报16.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483039246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483039246?lang=zh_cn&edition=full","pubTime":"2024-11-13 01:25","pubTimestamp":1731432306,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日01时25分，Intellia Therapeutics, Inc.股票出现波动，股价大幅下跌5.11%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.77%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113012506abbaa65d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113012506abbaa65d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861558580.USD","NTLA","BK4535","BK4139","BK4588","BK4585","LENZ","LU1861559042.SGD","BK4556"],"gpt_icon":0},{"id":"2482173844","title":"Intellia Therapeutics, Inc.盘中异动 早盘股价大涨5.22%报17.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482173844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482173844?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:37","pubTimestamp":1731335842,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时37分，Intellia Therapeutics, Inc.股票出现异动，股价大幅拉升5.22%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223722a22ce792&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223722a22ce792&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","LU1861559042.SGD","BK4556","NTLA","LENZ","BK4535","BK4585","LU1861558580.USD"],"gpt_icon":0},{"id":"2482431995","title":"Intellia Therapeutics, Inc.盘中异动 急速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482431995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482431995?lang=zh_cn&edition=full","pubTime":"2024-11-09 02:52","pubTimestamp":1731091925,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日02时52分，Intellia Therapeutics, Inc.股票出现波动，股价快速拉升5.00%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.26%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110902520598e418cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110902520598e418cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861558580.USD","BK4556","LU1861559042.SGD","BK4535","BK4588","NTLA","BK4139","LENZ","BK4585"],"gpt_icon":0},{"id":"2481293975","title":"Intellia Therapeutics, Inc.盘中异动 股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481293975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481293975?lang=zh_cn&edition=full","pubTime":"2024-11-07 01:46","pubTimestamp":1730915178,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日01时46分，Intellia Therapeutics, Inc.股票出现波动，股价快速上涨5.17%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107014618aba716a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107014618aba716a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","LU1861559042.SGD","BK4556","NTLA","LENZ","BK4535","BK4585","LU1861558580.USD"],"gpt_icon":0},{"id":"2479824522","title":"Intellia Therapeutics, Inc.盘中异动 快速跳水5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479824522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479824522?lang=zh_cn&edition=full","pubTime":"2024-10-29 22:57","pubTimestamp":1730213826,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日22时57分，Intellia Therapeutics, Inc.股票出现异动，股价快速跳水5.20%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029225706ab7f548d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029225706ab7f548d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861559042.SGD","BK4588","BK4556","LU1861558580.USD","BK4139","BK4585","NTLA","LENZ","BK4535"],"gpt_icon":0},{"id":"2478481951","title":"Intellia Therapeutics, Inc.盘中异动 早盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478481951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478481951?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:54","pubTimestamp":1730123640,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时54分，Intellia Therapeutics, Inc.股票出现波动，股价快速拉升5.14%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215400971a2a85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215400971a2a85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","NTLA","LU1861558580.USD","BK4535","BK4585","BK4556","LENZ","LU1861559042.SGD","BK4139"],"gpt_icon":0},{"id":"2478265937","title":"Intellia Therapeutics, Inc.盘中异动 早盘股价大涨5.05%报16.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478265937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478265937?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:15","pubTimestamp":1729869340,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日23时15分，Intellia Therapeutics, Inc.股票出现波动，股价大幅拉升5.05%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025231540ab7434e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025231540ab7434e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","LU1861558580.USD","LU1861559042.SGD","BK4588","NTLA","BK4585","BK4556","LENZ"],"gpt_icon":0},{"id":"2477630596","title":"BUZZ-基因治疗研究中期数据不尽如人意，Intellia业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2477630596","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477630596?lang=zh_cn&edition=full","pubTime":"2024-10-24 22:31","pubTimestamp":1729780273,"startTime":"0","endTime":"0","summary":"** HAE的特征是皮肤、胃肠道、上呼吸道系统、面部和喉咙不可预测地频繁出现严重肿胀。** 我们预计，考虑到体内基因编辑的潜在风险和该适应症的竞争格局，投资者会认为 HAE 发作减少 75-80% 的结果并不令人印象深刻。** 美国目前批准的HAE治疗药物包括武田药品  和BioCryst Pharmaceuticals  生产的药物。** 包括盘中走势在内，Intellia 的股价今年以来下跌了约 46","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLDYK493.USD","LU0205193047.USD","HAE","BK4198","LU1169590202.USD","LU0012050646.USD","NTLA","BK4139","LU0205194284.USD","BK4535","LU0106261612.USD","LU1861559042.SGD","IE00B64QTZ34.USD","BK4556","BK4588","LU1169589451.USD","BK4547","BCRX","LU1861558580.USD","BK4585"],"gpt_icon":0},{"id":"2477855532","title":"Intellia Therapeutics, Inc.盘中异动 急速跳水5.03%报20.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477855532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477855532?lang=zh_cn&edition=full","pubTime":"2024-10-24 00:21","pubTimestamp":1729700492,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日00时21分，Intellia Therapeutics, Inc.股票出现波动，股价快速下跌5.03%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.07%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102400213298e3e099&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102400213298e3e099&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4556","LU1861558580.USD","BK4535","NTLA","BK4585","LU1861559042.SGD","BK4139","LENZ"],"gpt_icon":0},{"id":"2475168569","title":"Intellia Therapeutics, Inc.盘中异动 快速拉升5.02%报20.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475168569","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475168569?lang=zh_cn&edition=full","pubTime":"2024-10-16 22:04","pubTimestamp":1729087443,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日22时04分，Intellia Therapeutics, Inc.股票出现异动，股价大幅上涨5.02%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.95%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101622040398e3cc90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101622040398e3cc90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861559042.SGD","BK4556","LENZ","BK4139","BK4535","NTLA","LU1861558580.USD","BK4588","BK4585"],"gpt_icon":0},{"id":"2475488303","title":"Intellia Therapeutics, Inc.盘中异动 临近收盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475488303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475488303?lang=zh_cn&edition=full","pubTime":"2024-10-15 03:45","pubTimestamp":1728935150,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日03时45分，Intellia Therapeutics, Inc.股票出现异动，股价快速拉升5.01%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101503455198e3c557&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101503455198e3c557&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NTLA","BK4588","BK4535","LU1861558580.USD","LU1861559042.SGD","BK4139","LENZ","BK4556","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.intelliatx.com","stockEarnings":[{"period":"1week","weight":-0.1856},{"period":"1month","weight":-0.3653},{"period":"3month","weight":-0.4296},{"period":"6month","weight":-0.4718},{"period":"1year","weight":-0.539},{"period":"ytd","weight":-0.5697}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0118},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.1153},{"period":"1year","weight":0.3028},{"period":"ytd","weight":0.2423}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Intellia Therapeutics, Inc.于2014年5月在特拉华州注册成立。该公司是一家领先的基因编辑公司，专注于利用最近开发的被称为CRISPR/ Cas9的系统生物工具进行的独特的、潜在治愈疗法的发展。公司认为CRISPR/ Cas9技术具有通过单一疗程永久编辑疾病相关的基因在人体内进行改造药物的潜力。该公司打算利用其领先的科学专业知识、临床开发经验和知识产权地位解锁CRISPR/ Cas9基因编辑广泛的治疗应用，发展有潜能的新一代治疗产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.014871},{"month":2,"riseRate":0.75,"avgChangeRate":0.078068},{"month":3,"riseRate":0.25,"avgChangeRate":-0.040105},{"month":4,"riseRate":0.375,"avgChangeRate":-0.074095},{"month":5,"riseRate":0.25,"avgChangeRate":0.030737},{"month":6,"riseRate":0.888889,"avgChangeRate":0.214578},{"month":7,"riseRate":0.555556,"avgChangeRate":0.022335},{"month":8,"riseRate":0.555556,"avgChangeRate":0.026121},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.069902},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.087409},{"month":11,"riseRate":0.555556,"avgChangeRate":0.099459},{"month":12,"riseRate":0.375,"avgChangeRate":-0.073139}],"exchange":"NASDAQ","name":"Intellia Therapeutics Inc","nameEN":"Intellia Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Intellia Therapeutics Inc(NTLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Intellia Therapeutics Inc(NTLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Intellia Therapeutics Inc,NTLA,Intellia Therapeutics Inc股票,Intellia Therapeutics Inc股票老虎,Intellia Therapeutics Inc股票老虎国际,Intellia Therapeutics Inc行情,Intellia Therapeutics Inc股票行情,Intellia Therapeutics Inc股价,Intellia Therapeutics Inc股市,Intellia Therapeutics Inc股票价格,Intellia Therapeutics Inc股票交易,Intellia Therapeutics Inc股票购买,Intellia Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Intellia Therapeutics Inc(NTLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Intellia Therapeutics Inc(NTLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}